scispace - formally typeset
X

Xiaojun Xu

Researcher at China Pharmaceutical University

Publications -  50
Citations -  1314

Xiaojun Xu is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Lipid metabolism & Medicine. The author has an hindex of 18, co-authored 45 publications receiving 894 citations. Previous affiliations of Xiaojun Xu include German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Regulation of mitochondrial morphology and function by stearoylation of TFR1

TL;DR: It is found that animal cells are poised to respond to both increases and decreases in C18:0 levels, with increased C 18:0 dietary intake boosting mitochondrial fusion in vivo and countering the mitochondrial dysfunction caused by genetic defects such as loss of the Parkinson’s disease genes Pink or Parkin in Drosophila.
Journal ArticleDOI

Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.

TL;DR: In this paper, the transketolase-like protein 1 (TKTL1) was inhibited by RNAi technologies in human HCT116 colon carcinoma cells, which resulted in a significantly slowed cell growth, glucose consumption and lactate production.
Journal ArticleDOI

Insulin Signaling Regulates Fatty Acid Catabolism at the Level of CoA Activation

TL;DR: It is shown here that an additional, important regulated step is the activation of fatty acids for beta-oxidation via Acyl Co-A synthetases (ACS), and a mechanistic link through which insulin regulates lipid homeostasis is identified.
Journal ArticleDOI

6-Shogaol induces apoptosis in human hepatocellular carcinoma cells and exhibits anti-tumor activity in vivo through endoplasmic reticulum stress.

TL;DR: The results indicate that the PERK/eIF2α pathway plays an important role in 6-shogaol-mediated ER stress and apoptosis in SMMC-7721 cells in vitro and in vivo.
Journal ArticleDOI

Bioactive equivalence of combinatorial components identified in screening of an herbal medicine.

TL;DR: This work answers the key question of which are real bioactive components for CP that have been used in clinic for many years, and provides a promising approach for discovering BECCs from herbal medicines.